Your browser doesn't support javascript.
loading
Estimating and explaining cross-country variation in the effectiveness of non-pharmaceutical interventions during COVID-19.
Banholzer, Nicolas; Feuerriegel, Stefan; Vach, Werner.
Afiliação
  • Banholzer N; ETH Zurich, Zurich, Switzerland. nbanholzer@ethz.ch.
  • Feuerriegel S; LMU Munich, Munich, Germany.
  • Vach W; Basel Academy for Quality and Research in Medicine, Basel, Switzerland.
Sci Rep ; 12(1): 7526, 2022 05 09.
Article em En | MEDLINE | ID: mdl-35534516
ABSTRACT
To control the COVID-19 pandemic, countries around the world have implemented non-pharmaceutical interventions (NPIs), such as school closures or stay-at-home orders. Previous work has estimated the effectiveness of NPIs, yet without examining variation in NPI effectiveness across countries. Based on data from the first epidemic wave of [Formula see text] countries, we estimate country-specific differences in the effectiveness of NPIs via a semi-mechanistic Bayesian hierarchical model. Our estimates reveal substantial variation between countries, indicating that NPIs have been more effective in some countries (e. g. Switzerland, New Zealand, and Iceland) as compared to others (e. g. Singapore, South Africa, and France). We then explain differences in the effectiveness of NPIs through 12 country characteristics (e. g. population age, urbanization, employment, etc.). A positive association with country-specific effectiveness of NPIs was found for government effectiveness, gross domestic product (GDP) per capita, population ages 65+, and health expenditures. Conversely, a negative association with effectiveness of NPIs was found for the share of informal employment, average household size and population density. Overall, the wealth and demographic structure of a country can explain variation in the effectiveness of NPIs.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça